BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 29247540)

  • 1. Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults.
    Serris A; Amoura Z; Canouï-Poitrine F; Terrier B; Hachulla E; Costedoat-Chalumeau N; Papo T; Lambotte O; Saadoun D; Hié M; Blanche P; Lioger B; Gottenberg JE; Godeau B; Michel M
    Am J Hematol; 2018 Mar; 93(3):424-429. PubMed ID: 29247540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus.
    Olfat M; Silverman ED; Levy DM
    Lupus; 2015 Aug; 24(9):966-72. PubMed ID: 25804672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Rituximab in Systemic Lupus Erythematosus and Sjögren Syndrome Patients With Refractory Thrombocytopenia: A Retrospective Study of 21 Cases.
    Jiang B; Li T; Guo L; Shen H; Ye S; Chen S
    J Clin Rheumatol; 2015 Aug; 21(5):244-50. PubMed ID: 26203828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome.
    Shanafelt TD; Madueme HL; Wolf RC; Tefferi A
    Mayo Clin Proc; 2003 Nov; 78(11):1340-6. PubMed ID: 14601692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose rituximab therapy in steroid-refractory thrombocytopenia due to systemic lupus erythematosus.
    Ilizaliturri-Guerra O; Uriarte-Botello R; Pineda-Sic RÁ; Serna-Peña G; Garza-Elizondo MA; Galarza-Delgado DÁ; Leal-Bramasco AS; Elizondo-Solís CV; Santoyo-Fexas L; Villarreal-Alarcón MÁ
    Rheumatol Int; 2020 Oct; 40(10):1717-1724. PubMed ID: 32797277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of a patient with refractory immune thrombocytopenic purpura in systemic lupus erythematosus with rituximab.
    Abe K; Ishikawa Y; Ishikawa J; Fujiwara M; Kita Y
    Immunol Med; 2019 Dec; 42(4):185-188. PubMed ID: 31794352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.
    Kumar S; Benseler SM; Kirby-Allen M; Silverman ED
    Pediatrics; 2009 Jan; 123(1):e159-63. PubMed ID: 19074962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti B-cell therapy against refractory thrombocytopenia in SLE and MCTD patients: long-term follow-up and review of the literature.
    Jovancevic B; Lindholm C; Pullerits R
    Lupus; 2013 Jun; 22(7):664-74. PubMed ID: 23612795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia.
    Rossignol J; Michallet AS; Oberic L; Picard M; Garon A; Willekens C; Dulery R; Leleu X; Cazin B; Ysebaert L
    Leukemia; 2011 Mar; 25(3):473-8. PubMed ID: 21127498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune haemolytic anaemia and autoimmune thrombocytopenia in childhood-onset systemic lupus erythematosus: updates on pathogenesis and treatment.
    Neely J; von Scheven E
    Curr Opin Rheumatol; 2018 Sep; 30(5):498-505. PubMed ID: 29979258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Whole-Blood Exchange Transfusion in Refractory Severe Autoimmune Haemolytic Anaemia Secondary to Systemic Lupus Erythematosus: A Real-World Observational Retrospective Study.
    Jiang Y; Zhao HJ; Luo H; Li BJ; Zhang ZM; Zhao LD; Zuo XX
    Front Immunol; 2022; 13():861719. PubMed ID: 35757744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Features of Systemic Lupus Erythematosus Patients Complicated With Evans Syndrome: A Case-Control, Single Center Study.
    Zhang L; Wu X; Wang L; Li J; Chen H; Zhao Y; Zheng W
    Medicine (Baltimore); 2016 Apr; 95(15):e3279. PubMed ID: 27082565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus is effective for primary relapsed/refractory autoimmune cytopenia: a multicenter study.
    Li H; Ji J; Du Y; Huang Y; Gu H; Chen M; Wu R; Han B
    Exp Hematol; 2020 Sep; 89():87-95. PubMed ID: 32771553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenence rituximab following induction in autoimmune cytopenias.
    Rai MP; Lee EJ; Bussel JB
    Br J Haematol; 2023 Jul; 202(1):153-158. PubMed ID: 37086173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases.
    Michel M; Chanet V; Dechartres A; Morin AS; Piette JC; Cirasino L; Emilia G; Zaja F; Ruggeri M; Andrès E; Bierling P; Godeau B; Rodeghiero F
    Blood; 2009 Oct; 114(15):3167-72. PubMed ID: 19638626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of treatment with Campath-1H in patients with autoimmune cytopenias.
    Willis F; Marsh JC; Bevan DH; Killick SB; Lucas G; Griffiths R; Ouwehand W; Hale G; Waldmann H; Gordon-Smith EC
    Br J Haematol; 2001 Sep; 114(4):891-8. PubMed ID: 11564082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
    Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A
    J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapses are common in severe hematologic systemic lupus erythematosus and may be prevented by early institution of immunosuppressive agents: Α real-life single-center study.
    Moysidou GS; Garantziotis P; Nikolopoulos D; Katsimbri P; Fanouriakis A; Boumpas DT
    Lupus; 2023 Feb; 32(2):225-230. PubMed ID: 36490217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 35 cases.
    Ramos-Casals M; García-Carrasco M; López-Medrano F; Trejo O; Forns X; López-Guillermo A; Muñoz C; Ingelmo M; Font J
    Medicine (Baltimore); 2003 Mar; 82(2):87-96. PubMed ID: 12640185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
    Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
    Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.